17 October 2017
News and Views
Links and Services
The most recent issue of the Clinical Gastroenterology & Hepatology evaluates the risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and mercaptopurine.
Thiopurine therapy for inflammatory bowel disease (IBD) has been associated with increased risk f
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors